Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Neochem Bio Solutions's quarterly market cap
stayed the same
from Mar. 2025 (₹0 Mil) to Sep. 2025 (₹0 Mil) but then
increased
from Sep. 2025 (₹0 Mil) to Mar. 2026 (₹1,083 Mil).
Neochem Bio Solutions's annual market cap
stayed the same
from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil) but then
increased
from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹1,083 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Neochem Bio Solutions's Enterprise Value for Today is ₹1,712 Mil.
Neochem Bio Solutions (NSE:NEOCHEM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neochem Bio Solutions Market Cap Chart
Neochem Bio Solutions Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Market Cap
0.00
0.00
0.00
1,082.90
Neochem Bio Solutions Semi-Annual Data
Mar23
Mar24
Mar25
Sep25
Mar26
Market Cap
0.00
0.00
0.00
0.00
1,082.90
NSE:NEOCHEM vs LIN, SHW, ECL: Market Cap Comparison
For the Specialty Chemicals subindustry, Neochem Bio Solutions's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neochem Bio Solutions Market Cap vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Neochem Bio Solutions's Market Cap distribution charts can be found below:
* The bar in red indicates where Neochem Bio Solutions's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Neochem Bio Solutions's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neochem Bio Solutions (NSE:NEOCHEM) has a Market Cap of ₹1,558 Mil as of Aug. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Neochem Bio Solutions and its competitors. According to the industry distribution chart, Neochem Bio Solutions ranks #1396 out of 1633 companies in the Chemicals industry, placing it in the top 85.5%.
Is Neochem Bio Solutions' Market Cap too high?
Neochem Bio Solutions' current Market Cap is ₹1,558 Mil. Based on the distribution chart, Neochem Bio Solutions ranks #1396 out of 1633 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Neochem Bio Solutions has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Neochem Bio Solutions' Market Cap compare to LIN and SHW?
According to the Chemicals industry distribution chart, Neochem Bio Solutions ranks #1396 out of 1633 companies for Market Cap. This places Neochem Bio Solutions in the lower half of its industry. The industry median Market Cap is 290.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Chemicals company?
The median Market Cap among Chemicals companies is 290.90, based on 1,633 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Neochem Bio Solutions and its competitors. For the Chemicals industry, the median Market Cap is 290.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neochem Bio Solutions's current Market Cap is ₹1,558 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neochem Bio Solutions stock overvalued right now?
Neochem Bio Solutions (NSE:NEOCHEM) has a current Market Cap of ₹1,558 Mil. The current Market Cap is ₹1,558 Mil. Neochem Bio Solutions' overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Neochem Bio Solutions (NSE:NEOCHEM), the current Market Cap is ₹1,558 Mil as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Neochem Bio Solutions Ltd is a specialty performance chemical company. Its primary product segments such as Polymers, Surfactants, Silicones, and Esters & bio-based sustainable solutions. The products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments.
18GF Score
Get the complete analysis for NSE:NEOCHEM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEOCHEM has been successfully added to your 
